Faina Shtern, MD, presented “NIH NCI Study on Focal Therapy” during the 33rd International Prostate Cancer Update on January 24, 2023, in Vail, Colorado.
How to cite: Shtern, Faina. “NIH NCI Study on Focal Therapy.” January 2023, 2023. Accessed Apr 2024. https://grandroundsinurology.com/nih-nci-study-on-focal-therapy/
NIH NCI Study on Focal Therapy – Summary
Faina Shtern, MD, presents a review of image-guided focal therapy in diagnosing and treating localized prostate cancer. Dr. Shtern examines the benefits of minimally-invasive, image-guided focal therapy combined with radiogenomics using studies from the National Institutes of Health and the National Cancer Institute.
Dr. Shtern discusses the importance of using radiogenomics, a combination of MRI and genetic cancer profiling, in diagnosing localized prostate cancer, as some prostate cancer lesions may not appear on an MRI alone. Using radiogenomics in patient diagnosis can help practitioners determine the appropriateness of image-guided focal therapy as a treatment, and provides a comprehensive picture for monitoring the patient post-treatment.
About The 33rd Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 33rd iteration of the meeting occurred January 22-25, 2023 in Vail, Colorado. To view more educational presentations from IPCU 33, visit our collection page.
